Results 111 to 120 of about 56,178 (231)
Most state EMS protocols provide guidance on management of agitated patients, including use of physical restraints and chemical sedatives, yet older adult‐specific modifications or dosing guidance are uncommon. ABSTRACT Background Agitation in older adults presents unique challenges for emergency medical services (EMS) clinicians.
Joshua Lachs +9 more
wiley +1 more source
ABSTRACT Aim To examine triggers, responses, and outcomes for patient‐related violence and/or aggression events during acute hospitalisation. Design This was a descriptive observational study undertaken at two healthcare organisations. Methods Pre‐existing data were extracted from organisational incident reports and individual medical records during a ...
Debra Kerr +10 more
wiley +1 more source
Introduction: Treatment of bipolar disorders has evolved over the years from conventional mood stabilizers to second-generation antipsychotics. Among the atypical antipsychotics, few have been approved by Food and Drug Administration as treatment of ...
Ajeet Sidana, Prannay Gulati, B S Chavan
doaj +1 more source
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Objective Behavioral activation (BA) is an established treatment for depression in older adults, yet BA has been relatively less examined as a treatment for the negative symptoms (NS) of schizophrenia spectrum disorder (SSD). We here aimed to demonstrate the feasibility and proof‐of‐concept that BA can improve NS and function in older adults with SSD ...
Stephen F. Smagula +2 more
wiley +1 more source
Oppositional Defiant Disorder and Aggression in a Young Man with Mental Retardation: Long-Term Treatment in a Community-Based Setting [PDF]
A longitudinal, intensive treatment program is described that was implemented over an 8-year period in a community-based setting for a young man with mental retardation and oppositional defiant disorder with severe physical aggression. The development of
Barcelona, Amber L. +2 more
core +1 more source
Learning Outcomes That Maximally Differentiate Psychiatric Treatments
ABSTRACT Objectives To develop a statistical method that uncovers clinically meaningful differences between active psychiatric treatments, even when traditional rating scales fail to do so. Methods We introduce Supervised Varimax (SV), a novel algorithm that transforms individual items from clinical rating scales into a small set of optimized outcomes ...
Eric V. Strobl, Semmie Kim
wiley +1 more source
In chronic schizophrenia, serum adiponectin levels were positively associated with antipsychotic dosage, particularly with multi‐acting receptor‐targeted antipsychotics and were influenced by gender and hospitalization period. These findings highlight gender‐specific metabolic regulation and the importance of monitoring adipokines during long‐term ...
Yasuhiro Ohno +6 more
wiley +1 more source
Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
Clozapine (CLOZ) is often avoided in treatment‐resistant schizophrenia with comorbid epilepsy due to seizure risks. We report a successful case managed through a cautious CLOZ titration guided by multimodal monitoring, including clinical scales and blood tests such as C‐reactive protein (CRP), CLOZ levels, and anti‐seizure medication (ASM) levels ...
Toru Horinouchi +5 more
wiley +1 more source
Olanzapine: Are Extrapyramidal Symptoms as Rare as We Think? – A Case Series
Olanzapine, a second-generation antipsychotic has proven to be very efficacious with a low probability of extrapyramidal symptoms (EPS). Here, we wish to report a series of cases where EPS is occurring as a rare side effect due to olanzapine.
Akansha Bhardwaj +3 more
doaj +1 more source

